Delivery Order SPE2DB22D3501-SPE2DB25FVC41

Award Date 3/31/25
Potential Completion Date 4/1/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.47 Firm Fixed Price Delivery Order contract is for the supply of ABILIFY MAINTENA ER 300 MG VLS, a specialty medication. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.17 firm fixed price delivery order is for the supply of ABILIFY MAINTENA ER 300 MG VLS, a mental health treatment medication. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,672.33 firm fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a mental health medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,735.67, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of ABILIFY MAINTENA ER 300 MG VLS, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,842.17 firm fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,412.67, is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,487.08, is a delivery order for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a specialty medication. The contract has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,955.85 Firm Fixed Price Delivery Order is for the supply of 4562252756 ABILIFY MAINTENA ER 400 MG SYRS, with a completion date of September 21, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,614.02, is for the supply of ABILIFY MAINTENA ER 300 MG SYRS, a mental health treatment medication. The contract has an ultimate completion date of April 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award, valued at $2,020.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. There is no set-aside...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVC41
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,382.43 firm fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 300 MG SYRS, a prescription medication. The contract has an ultimate completion date of April 1, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 6/30/25, 10:44 AM